Client Challenge

Client Challenge

Client Challenge JavaScript is disabled in your browser. Please enable JavaScript to proceed. A required part of this site couldn’t load. This may be due to a browser extension, network issues, or browser settings. Please check your connection, disable any ad blockers, or try using a different browser. #Client #Challenge

A Little Good News for Ford Investors

A Little Good News for Ford Investors

Ford Motor Company announced a $19.5 billion special charge to pivot its strategy away from full-electric vehicles. Ford has outperformed U.S. industry sales for 10 consecutive months. The company’s hybrid sales set an annual sales record in 2025. 10 stocks we like better than Ford Motor Company › In a move that surprised some investors … Read more

ISCV vs. IJJ: The Rising Small-Cap ETF That Challenges the Popular Mid-Cap ETF

ISCV vs. IJJ: The Rising Small-Cap ETF That Challenges the Popular Mid-Cap ETF

Key Points Both the iShares SP Mid-Cap 400 Value ETF (NYSEMKT:IJJ)and the iShares Morningstar Small-Cap Value ETF (NYSEMKT:ISCV) invest in similar markets, but differ in size, cost, and market cap focus. IJJ focuses on mid-cap value, while ISCV tilts toward smaller companies with a broader portfolio and lower fees. Snapshot (cost & size) Metric IJJ … Read more

Client Challenge

Client Challenge

Client Challenge JavaScript is disabled in your browser. Please enable JavaScript to proceed. A required part of this site couldn’t load. This may be due to a browser extension, network issues, or browser settings. Please check your connection, disable any ad blockers, or try using a different browser. #Client #Challenge

Heron Therapeutics sees Q4 revenue $40.5M, consensus $39.83M

Heron Therapeutics sees Q4 revenue .5M, consensus .83M

“We are encouraged by the growth in Q4 2025, driven in particular by the momentum in our Acute Care franchise with ZYNRELEF and APONVIE,” said Craig Collard, CEO. “In addition to our revenue growth, we are extremely pleased with the continued progress made across all aspects of our business throughout the past year.” Preliminary Q4 … Read more

×